Jonathan Schechter's Net Worth

$46.9 Thousand

Estimate Recalculated Sep 11, 2024 12:43AM EST

Who is Jonathan Schechter

Jonathan Schechter does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Atrinsic, Inc., Synaptogenix, Inc., WPCS INTERNATIONAL INC, Neurotrope, Inc., PharmaCyte Biotech, Inc., and Oblong, Inc..

SEC CIK

Jonathan Schechter's CIK is 0001619259

Past Insider Trading and Trends

2020 was Jonathan Schechter's most active year for acquiring shares with 6 total transactions. Jonathan Schechter's most active month to acquire stocks was the month of March. 2020 was Jonathan Schechter's most active year for disposing of shares, totalling 7 transactions. Jonathan Schechter's most active month to dispose stocks was the month of November. 2020 saw Jonathan Schechter paying a total of $79,442.50 for 165,000 shares, this is the most they've acquired in one year. In 2022 Jonathan Schechter cashed out on 20,250 shares for a total of $23,730.97, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Atrinsic, Inc.

Investor
Updated Sep 12, 2014
Form 3
Sep 12, 2014
Showing 1 results

Synaptogenix, Inc.

Investor
Updated Apr 10, 2024
Form 4
800.00
Apr 10, 2024
800.00
Grant
Apr 08
Form 4
20.00K
Mar 31, 2023
20.00K
Grant
Mar 29
Form 4
-41.54%
-20.25K
$1.17
-$23.73K
Dec 20, 2022
28.50K
Sale
ScheduledDec 16
Form 4
72.00K
Nov 17, 2022
72.00K
Grant
Nov 15
Form 4/A
Jun 23, 2022
Acq/Dis
Apr 05
Form 4
1.50K
Apr 06, 2022
1.50K
Grant
Apr 05
Form 4
1,200.00%
45.00K
Jul 15, 2021
48.75K
Grant
Jul 13
Form 3/A
Jun 17, 2021
3.75K
Form 3
Jun 14, 2021
2.50K
Showing 9 results

WPCS INTERNATIONAL INC

Investor
Updated Apr 06, 2017
Form 3
Apr 06, 2017
Showing 1 results

Neurotrope, Inc.

Investor
Updated Dec 03, 2020
Form 4
-100.00%
-169.38K
Dec 03, 2020
Disposition
Dec 01
Form 4
80.00K
Nov 27, 2020
80.00K
Grant
Nov 24
Form 4
50.00%
25.00K
$0.98
$24.44K
Nov 02, 2020
75.00K
Purchase
Oct 30
Form 4
100.00%
25.00K
$1.10
$27.50K
Oct 26, 2020
50.00K
Purchase
Oct 22
Form 4
25.00K
$1.10
$27.50K
Oct 22, 2020
25.00K
Purchase
Oct 20 - Oct 21
Form 4
10.00K
Mar 24, 2020
10.00K
Grant
Mar 20
Form 4
10.00K
Apr 15, 2019
10.00K
Grant
Mar 15
Form 4
10.00K
Jan 24, 2019
10.00K
Grant
Jan 22
Form 4
9.38K
Dec 17, 2018
9.38K
Grant
Dec 13
Form 3
Dec 17, 2018
Showing 10 results

PharmaCyte Biotech, Inc.

Investor
Updated Jul 17, 2024
Form 4
38.01K
Jul 17, 2024
38.01K
Grant
Apr 30
Form 4
61.25K
Nov 22, 2023
61.25K
Grant
Nov 20
Form 3
Aug 23, 2022
50.00K
Showing 3 results

Oblong, Inc.

Investor
Updated Jun 01, 2023
Form 3
Jun 01, 2023
Showing 1 results